Search - tctmd.com

Displaying 201 - 220 of 233

Sort: Relevancy | Date

News Daily News

Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel

Todd Neale

February 05, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Daily News

Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias

Yael L. Maxwell

January 12, 2015

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Daily News

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

L.A. McKeown

November 17, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Conference News ACC 2014

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Jason Kahn

March 29, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

Advertisement

Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content